Liability to substance use disorders: 2. A measurement approach. - Wikidata - wikimedia - TriplyDB

Liability to substance use disorders: 2. A measurement approach.

Liability to substance use disorders: 2. A measurement approach.

http://www.wikidata.org/entity/Q35576335

about

Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective Risk and resistance perspectives in translation-oriented etiology research Quick screen to detect current substance use disorder in adolescents and the likelihood of future disorder.Measuring liability for substance use disorder among college students: implications for screening and early intervention.Does stress mediate the development of substance use disorders among youth transitioning to young adulthood?The AVPR1A gene and substance use disorders: association, replication, and functional evidence.Measuring addiction propensity and severity: the need for a new instrument Assessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood.A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework.Externalizing behavior and emotion dysregulation are indicators of transmissible risk for substance use disorder Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability.Deviant socialization mediates transmissible and contextual risk on cannabis use disorder development: a prospective study.Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions Does the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?Genetic relationship between the addiction diagnosis in adults and their childhood measure of addiction liability Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes Computer adaptive testing of liability to addiction: identifying individuals at risk.Does the "gateway" sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy.Longitudinal Modeling of the Association Between Transmissible Risk, Affect During Drug Use and Development of Substance Use Disorder Application of person-centered medicine in addiction.Physical maturation, peer environment, and the ontogenesis of substance use disorders.Neurobiological processes in adolescent addictive disorders.Age of alcohol and cannabis use onset mediates the association of transmissible risk in childhood and development of alcohol and cannabis disorders: evidence for common liability.Temperament disturbances measured in infancy progress to substance use disorder 20 years later.Prediction of cannabis use disorder between boyhood and young adulthood: clarifying the phenotype and environtype.Longitudinal modeling of transmissible risk in boys who subsequently develop cannabis use disorder Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys.PTSD contributes to teen and young adult cannabis use disorders.High and low neurobehavior disinhibition clusters within locales: implications for community efforts to prevent substance use disorder.Modeling the association between sexual maturation, transmissible risk, and peer relationships during childhood and adolescence on development of substance use disorder in young adulthood.Identifying childhood characteristics that underlie premorbid risk for substance use disorders: socialization and boldness.Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study Informing Prevention and Intervention Policy Using Genetic Studies of Resistance.Item Response Theory Analysis to Assess Dimensionality of Substance Use Disorder Abuse and Dependence Symptoms.Introduction to Metrics in Person Centered Medicine Research.Global white matter microstructural abnormalities associated with addiction liability score in drug naïve youth.Revisiting the concepts of risk and protective factors for understanding the etiology and development of substance use and substance use disorders: implications for prevention.

P2860

Q24603044-0C754544-2DCD-4812-89EC-188B9F8A18A8 Q26751398-ED3F42E8-1F4A-44B5-9E87-FD3BBE42491A Q30531050-88C891FD-D20A-4173-8946-18366312E4E2 Q33692854-DFC96A35-DB80-462D-8D41-90C0185BAA19 Q33709027-800B3664-3564-4674-AA35-29AAD3DA3BD1 Q33852455-647D3E3B-59B0-4759-8A0D-8F391744BFB7 Q34091899-840BBB33-9A11-4ED7-8393-380D4845608F Q34448089-957FA5D5-F83B-4768-A982-50FD3C98B68A Q34714161-A02FAD29-4D49-4B09-B6DC-696986AD5E07 Q34749082-C7A6BBB7-F9C9-49D0-AA22-98C0E515CD2D Q34997165-EC263843-3F89-452C-836C-AC5D3B5C3538 Q35023958-8B110493-A110-4CBA-B0EA-56EC75D142CC Q35250493-3298D72F-29CF-4618-80DE-CE23976E8506 Q35618764-60330F36-747D-4847-98C6-6F6DA002A762 Q35653685-4919577C-F4C2-4EDF-B1EE-8AB2A0A337E4 Q35899209-47FE2821-0B69-44D2-959A-030B002B02B1 Q36016324-956FDBD1-8055-408F-9A05-F8745A38BFC6 Q36069581-EB1BF66F-1317-4745-B33D-94E24E7F3A60 Q36240410-6FD21023-BF02-4584-9031-D2263A01E15A Q36461957-02FB82F7-EACE-4D80-B231-775956FC7CF2 Q36508612-F6B3E4AC-D325-4542-BE43-FD55DFF53346 Q36508688-B362F8D3-3E14-421A-985B-76F118E03CB0 Q36589256-8933179B-AABE-4251-BBA0-C35D7223DB35 Q36593025-8F34E3F6-05E4-4E33-B921-4A0CF4439653 Q37109598-E34FA4BE-80B2-425C-96FD-182E89BE9DF1 Q37119485-27C3AB9F-90A7-46BF-B46D-EF96576F3686 Q37157279-8918E81D-94F6-4413-BA74-75993F29C66C Q37380642-E91EDC9D-162B-4A5D-9BC2-5FEE0937C595 Q37442546-8C2A355B-EB8A-4CB8-950B-7B16809F75D5 Q37551239-29DE9C80-4F8F-45C5-8B52-8DC901312EA1 Q37561548-BA47989E-B32F-42F0-8929-C74BE6F718A5 Q37624336-D62E8EC9-843B-4A47-AA65-6710CA0C431F Q37667076-DE51B1BB-274A-4FA8-BA1D-6F1DB8B013B1 Q39301048-D1E23D50-4491-4ADB-920C-ED30484888C0 Q41714127-DE5EC50B-1824-4550-A9F9-1F801282B74C Q47094917-E6F668B3-B572-4F86-A0EC-4E506913A1FA Q48274343-FF94A7BB-5C61-4D92-AFFE-7B3CA8E1391B Q50803041-3F4F8508-B082-42B5-BB6C-B100E57251C7

P2860

Liability to substance use disorders: 2. A measurement approach.

http://www.wikidata.org/entity/Q35576335

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Liability to substance use disorders: 2. A measurement approach.

@ast

Liability to substance use disorders: 2. A measurement approach.

@en

type

label

Liability to substance use disorders: 2. A measurement approach.

@ast

Liability to substance use disorders: 2. A measurement approach.

@en

prefLabel

Liability to substance use disorders: 2. A measurement approach.

@ast

Liability to substance use disorders: 2. A measurement approach.

@en

P1433

Q35576335-ED6C8414-456D-40BE-825E-37C2C687A28D

P1476

Q35576335-439A5D4E-C928-40CE-9CFE-7ECD3F50649B

P2093

Q35576335-22397DF7-C93F-4F1E-9714-0A5ADFF776D9

Q35576335-84AE7A1F-3932-4BA7-AF7C-480F8E349D30

Q35576335-C614E71B-64B0-46AC-839C-6921B309A1CD

Q35576335-D6310FAB-7CFC-411A-B24F-B9EA02B06D30

Q35576335-D855EE12-DDE4-474E-8B29-FE6BEF1BC3D6

Q35576335-E18BD350-5EA4-4A57-A44B-132A42D6947A

Q35576335-ED8A65A7-24DF-4C3B-B159-3BAC0DAD0D92

P304

Q35576335-095D0DF4-4F31-43B8-8A0E-F5A7A4A16324

P31

Q35576335-1C558FBF-5DA8-46B3-8950-40505C4EADD5

P356

Q35576335-3743D794-0683-4324-9329-C01DB13B3ECD

P433

Q35576335-CA1D0D29-3337-41A1-A865-A1B9EF4F64E4

P478

Q35576335-F7C5D3B5-28BA-4DD4-8AFD-5A3F47DE2BEC

P577

Q35576335-130A92CC-CFB5-440B-96BF-E4F89AE11304

P698

Q35576335-750C795F-3314-4D71-A540-C6D4691DD12A

P356

J.NEUBIOREV.2003.08.003

P1433

Neuroscience & Biobehavioral Reviews

P1476

Liability to substance use disorders: 2. A measurement approach.

@en

P2093

Brion S Maher

http://www.w3.org/2001/XMLSchema#string

Duncan B Clark

http://www.w3.org/2001/XMLSchema#string

Galina P Kirillova

http://www.w3.org/2001/XMLSchema#string

Howard F Simkevitz

http://www.w3.org/2001/XMLSchema#string

Levent Kirisci

http://www.w3.org/2001/XMLSchema#string

Michael M Vanyukov

http://www.w3.org/2001/XMLSchema#string

Ralph E Tarter

http://www.w3.org/2001/XMLSchema#string

P304

517-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUBIOREV.2003.08.003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14599433

http://www.w3.org/2001/XMLSchema#string